News
Medical Device Network on MSN3d
Inquis’ thrombectomy system meets primary endpoints in PE treatment trialThe investigational device exemption trial enrolled 130 acute intermediate-risk pulmonary embolism patients across 22 US ...
Pulmonary arterial hypertension (PAH ... interim analysis has required a study to be stopped due to efficacy. The findings were presented at the American College of Cardiology 2025 Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback